{
    "medicine_id": "41f23015fcdcf2f56dbfd49cbbfe648855455cc9",
    "platform_id": "13688",
    "metadata": {
        "name": "Sovaldi 150 mg coated granules in sachet",
        "composition": "Sovaldi 150 mg coated granules in sachet Each sachet contains 150 mg sofosbuvir",
        "clinical_particulars": {
            "therapeutic_indications": "Sovaldi is indicated in combination with other medicinal products for the treatment of chronic hepatitis C CHC in adult and paediatric patients aged 3 years and above see sections 4 2 4 4 and 5 1 For hepatitis C virus HCV genotype specific activity see sections 4 4 and 5 1",
            "contraindications": {
                "disease": "Hypersensitivity to the active substance or to any of the excipients listed in section 6 1 Medicinal products that are strong P glycoprotein P gp inducers in the intestine carbamazepine phenobarbital phenytoin rifampicin and St John s wort Co administration will significantly decrease sofosbuvir plasma concentration and could result in loss of efficacy of Sovaldi see section 4 5",
                "pregnancy": "Applicable",
                "machine_ops": "Applicable",
                "excipients": "Lactose monohydrate;Microcrystalline cellulose;Croscarmellose sodium;Hydroxypropyl cellulose;Colloidal anhydrous silica;Sodium stearyl fumarate;Hypromellose;Macrogol 400;Amino methacrylate copolymer;Talc;Stearic acid;Sodium lauryl sulfate;Colloidal anhydrous silica",
                "incompatibilities": "Not applicable."
            }
        },
        "revision_date": "2021-05-11"
    }
}